Peter Armenio focuses his practice on the trial and appeal of patent infringement actions. As lead counsel representing defendants, Peter has defeated more than $1 billion in damages claims by jury trial or arbitration, and eliminated another more than $1 billion in damages claims by summary judgment or other pre-trial proceedings. As lead counsel representing plaintiffs, Peter has protected more than $10 billion in branded pharmaceutical sales, and won jury trial damages for his medical device clients.
Peter has been recognized by Chambers USA as a leading lawyer in intellectual property every year since 2007. Chambers has noted in various years that Peter is a "talented patent litigator" who is "well versed," "professional," and has a "track record of winning."
Peter has also been selected by his peers as a New York SuperLawyer in intellectual property litigation after polling and research by Law & Politics, a division of Key Professional Media, Inc., and is listed in Euromoney's "Guide To The World's Leading Patent Law Practitioners," Who's Who Legal's "International Who's Who of Patent Lawyers," and IAM's "Life Sciences 250."
American Express
Covidien
Forest Laboratories
GlaxoSmithKline
Tyco Healthcare Group
Lead trial counsel for Tyco Healthcare Group LP in patent infringement litigation brought to enforce its surgical trocar patent rights, obtaining a jury verdict of infringement and damages
Lead trial counsel for H. Lundbeck A/S and Forest Laboratories Inc. in patent infringement litigation brought against the manufacture and sale of their LEXAPRO® and CELEXA® brand antidepressants, obtaining judgment as a matter of law of invalidity
Lead trial counsel for Schering-Plough Corp. in multiple Hatch-Waxman patent infringement litigations regarding its CLARINEX® brand antihistamines, obtaining injunctions preventing any generic competition until 2012
Lead trial counsel for GlaxoSmithKline in a breach of contract litigation brought against its performance under a prior ANDA settlement, obtaining a dismissal of all claims at the pleadings stage
Lead trial and appellate counsel for American Express Co. in patent infringement litigation brought against its gift card products, obtaining final judgment in favor of American Express at the Markman hearing and a Federal Circuit affirmance
Lead trial counsel for Boston Scientific Corp. in a WIPO patent infringement arbitration brought against its LIBERTE® and TAXUS LIBERTE® brand cardiovascular stents, obtaining a Tribunal judgment of non-infringement
Lead trial counsel for Tyco Healthcare Group LP in patent infringement litigation brought against its surgical trocar products, obtaining a dismissal of all claims with prejudice in three actions after a combined Markman hearing
Lead trial counsel for Meda Pharmaceuticals, Inc. in multiple Hatch-Waxman patent infringement litigations brought to protect its ASTELIN® brand anti-allergy nasal spray, obtaining four consent judgments with permanent injunctions
Seton Hall University School of Law (J.D., summa cum laude, 1994)
Seton Hall Law Review
West Publishing Award for Outstanding Scholastic Achievement
Bucknell University (B.A., Chemistry, 1990)
Kirkland & Ellis LLP:
Partner, 2000-2010
Associate, 1996-2000
Fitzpatrick, Cella, Harper & Scinto:
Associate, 1994-1996
Member, The American Bar Association
Member, The American Chemical Society
New Jersey Intellectual Property Law Association (NJIPLA), March 2006, "Current Issues in Hatch-Waxman ANDA Litigation"
New Jersey Intellectual Property Law Association (NJIPLA), March 2004, "NJIPLA Patent Litigation Seminar," panelist for session "Managing Patent Litigation"
Eurolegal, October 2002, "Supplemental Protection Certificates And Their U.S. Equivalents"
American Conference Institute (ACI), May 2002, "Pharmaceutical Patent Lifecycles," panelist for session "How The Latest Trends In Claim Construction Are Affecting Your Company's Patent Protection Strategy"
Pharmaceutical International Lawyers Legal Seminars (PILLS), January 2002, "ANDA Litigation Update"
Pharmaceutical International Lawyers Legal Seminars (PILLS), January 2000, "Developments In U.S. Patent Litigation Strategies"
Licensing Executives Society (LES), October 1999, "Collaborating Effectively: Working With Others While Protecting Your IP"